19 Mar 2020 Virox Animal Health – COVID-19
Virox Animal Health (Virox Technologies Inc.) continues to closely monitor the COVID-19 pandemic (SARS-CoV-2) and its impact on both our end users and distribution partners. Our number one priority is to help ensure the health and safety of every person and animal affected by the current outbreak. As time is of the essence when implementing a standard infection prevention protocol during a pandemic, we have more than doubled production of our Accelerated Hydrogen Peroxide® disinfectants to ensure uninterrupted supply at this critical time.
Virox Animal Health (Virox Technologies Inc.) continues to closely monitor the COVID-19 pandemic (SARS-CoV-2) and its impact on
both our end users and distribution partners.
Our number one priority is to help ensure the health and safety of every person and animal affected by the current outbreak. As time is of the essence when implementing a standard infection prevention protocol during a pandemic, we have more than doubled production of our Accelerated Hydrogen Peroxide® disinfectants to ensure uninterrupted supply at this critical time.
Supply Chain:
Since the initial reports of this virus in Wuhan, China, Virox Technologies initiated our outbreak protocols. Assessing our supply chain for components, raw materials, logistics and production capabilities in anticipation of this increased demand. As we began to ramp up production, we also began to stockpile raw materials, components and finished products within local warehousing to allow for better on demand supply.
Production:
As demand increased for infection prevention products, such as disinfectants, several measures were put into plan to ensure adequate supply through our distribution channels. These include:
- A seven-day production week running 24 hours a day on high volume lines
- Secured enough components and chemicals to supply the increased demand
- Worked closely with our logistic partners to maintain consistent flow of goods
Distribution:
Like other in demand products, Virox has seen a sharp increase in orders. We are working closely with our distribution and private label partners to manage the flow of inventory which is available to our end users. We believe we are prepared to continue to service and supply this increased demand effectively as the need continues to grow.
Worker Safety:
We believe our biggest asset is our employees. Without our hard-working team we would not be able to fulfill our demand. Therefore, effective immediately we instituted a plan to help minimize the risk to our employees. This plan includes, restricted travel, work from home options, and an additional sick day policy. We also increased current disinfection protocols around the office to ensure the health and safety of those still requiring to come into our office and facility.
Learn More:
As this is a rapidly evolving situation, Virox Technologies will continue to monitor the CDC website for resources and further guidance. In the meantime, we recommend that the general public continue to observe good personal hygiene practices, including hand washing, respiratory hygiene and cough etiquette, as well as surface disinfection using a Health Canada or EPA-registered product. Visit the CDC website to learn more.